Stakeholder feedback on the draft WA Health Genomics Strategy 2021

Closed 31 Jan 2021

Opened 10 Dec 2020

Feedback updated 5 Dec 2022

We asked

The Office of Population Health Genomics asked stakeholders for their feedback on the draft WA Genomics Strategy and their views to inform the development of the strategy’s first implementation plan.

The strategy has one overarching vision – that all Western Australians benefit from the timely and appropriate translation of genomics, enabling precision medicine and precision public health.

You said

A total of 66 responses were received through Citizen Space and 2 written responses were received via email. The key themes that emerged from the responses are summarised below.


  • More than 20 respondents explicitly agreed with or made positive comments about the vision.
  • More than 10 respondents commented on the term “maximise the transformative potential”, suggesting that it was either too ambiguous or not beneficial to include.
  • Some respondents suggested that the vision needed to be more patient focussed.

Underlying principles:

  • All comments received were positive and in support of the underlying principles.
  • Some additional principles were suggested for inclusion – the most mentioned ones being innovation, privacy and confidentiality, accountability, integrity, and collaboration.
  • A couple of respondents suggested that seven underlying principles was too many.

Enablers of success:

  • The feedback received was overall supportive of the enablers of success.
  • There were mixed responses around what “governance” should encompass, indicating that this word can take on different meanings for different stakeholder groups.
  • Eight respondents commented on the critical need for reliable and ongoing funding, suggesting that this should be an enabler of success.

Priority areas, goals and initiatives:

  • More than 20 respondents explicitly agreed with or made positive comments about the priority areas.
  • More than 10 respondents suggested including more detail on the needs, preferences and roles of various stakeholder groups relevant to genomics, i.e. carers and guardians beyond immediate family members, peer support groups, regional and remote patients and staff, allied health professionals, not-for-profit organisations, and the private sector.
  • Other factors important to multiple stakeholder groups were:
    • Co-design and co-production with health consumers
    • Secure and sustainable funding of the genomics workforce and services to ensure continuation and growth
    • Improving the genomic literacy of health professionals and consumers
    • Ethical use of genomic data
    • Equity of access.

Stakeholders also provided valuable input to shape the content of the strategy’s implementation plan, particularly the key actions to complete in the first two years.

We did

In response to the feedback, the Office of Population Health Genomics:

  • Amended the vision to be clearer.
  • Consolidated the number of underlying principles from seven to four and incorporated the additional principles suggested by stakeholders in the process. The only exceptions were accountability and collaboration, as they were already included as enablers of success.
  • Removed governance from the enablers of success to minimise confusion. Governance is instead covered in the conclusion section with additional details on what the strategy’s governance structure will look like for additional clarity.
  • Amended the content of the strategic priorities to better reflect stakeholders’ values and views, including:
    • Referring to a multi-professional genomics workforce and incorporating vignettes to acknowledge the diverse applications and many successes of genomics in WA.
    • Emphasising the critical role of health consumers in the co-creation (i.e. co-design and co-production) of genomic healthcare services and policies.
    • Elevating sustainable investment as an enabler of success to signify that this is critical to ensure the goals of all strategic priorities are met.
    • Expanding on the importance of genomic and health literacy for both health professionals and consumers.
    • Highlighting the need to protect privacy and trust with all community members.
  • Considered stakeholder’s views in drafting the strategy’s first implementation plan (internal working document).

The final WA Genomics Strategy 2022-2032: Towards precision medicine and precision public health is now available to view here.

Any queries can be directed to


The purpose of this consultation is to seek stakeholders' feedback in relation to the draft WA Health Genomics Strategy 2021 (‘Strategy’) and their opinions to inform the development of the first implementation plan. This consultation consists of two parts:

  • Part 1 will seek feedback on the draft Strategy; in particular the vision, underlying principles, enablers of success, key priority areas, goals, and initiatives.
  • Part 2 will seek opinions on the three horizons proposed for the Strategy's implementation and priority actions for focussing efforts and resources in the first two years.

The consultation should take you approximately 15-30 minutes to complete, depending on your level of feedback.

If at anytime you would like to pause and continue at a later time, please select the “Save and come back later…” button at the bottom of the page. All responses received will remain confidential and used only for the purposes of informing the final Strategy and its first implementation plan.

About the Strategy

The Strategy presents a shared vision for all stakeholders, key strategic priority areas and recommended initiatives to lead and coordinate the efficient, effective, ethical and equitable translation of genomics knowledge in the WA health system. The draft Strategy (link provided above) was informed by considerable stakeholder engagement that began in September 2019. This included:

  • Over 40 personal interviews with a range of stakeholders including clinicians, medical researchers, laboratory scientists and policy-makers;
  • Personal interviews and an online consultation with people who have a lived experience of genomics through the WA health system;
  • Small group stakeholder workshops; and
  • Advice received from the WA Health Genomics Strategy Advisory Committee, which consists of representatives from each Health Service Provider and a range of subject matter experts relevant to health genomics.

A discussion paper outlining the key findings from the initial stakeholder engagement is provided here for your information. Further background on genetics and genomics can be found at this link here.

The Office of Population Health Genomics, at the WA Department of Health is leading the development of the Strategy.


  • Health Network Leads
  • Consumers
  • Doctors
  • External Agencies
  • WA Health Service Providers
  • Department of Health Executive
  • Public and Aboriginal Health Division
  • HealthPathways
  • WA Health services and staff
  • Universities
  • Contracted service providers
  • Aboriginal health
  • Health professionals
  • Health workforce
  • Primary Care
  • Researchers
  • Policy
  • Planning
  • Consumers
  • Carers
  • Health Service Providers
  • WA Health
  • Department of Health
  • Allied Health
  • Doctors
  • Nurses
  • Aboriginal Health
  • Carers
  • Consumer
  • Medicare Local
  • Midwife
  • Non Government Organisations
  • Population Health
  • Prevention Professionals
  • Policy
  • Planning
  • Primary Care Teams
  • Researchers
  • Academics
  • HealthPathways WA
  • External agencies


  • Consumer/carer/community engagement
  • Cancer
  • Child and Youth Health
  • Genetics
  • Infections and Immunology
  • Musculoskeletal
  • Neurosciences and the Senses
  • Primary Care
  • Renal Health
  • Respiratory Health
  • Women's and Newborn's
  • Pathways
  • Health Network Leads
  • Cardiology
  • Child Health
  • Endocrinology
  • Infectious Diseases
  • Opthalmology
  • Pharmacology
  • Respiratory